Drug Trial Radar · NCT01163032
Efficacy and Safety of Tasimelteon Compared With Placebo in Totally Blind Subjects With Non-24-Hour Sleep-Wake Disorder
Last checked: Nov 19, 2026Latest source record: Oct 16, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
136
Actual
Start
Aug 2010
Primary completion
Nov 2012
Study completion Nov 2012
Sponsor
- Lead sponsor
- Vanda PharmaceuticalsIndustry
- Sponsor type
- Industry
- First posted
- Jul 15, 2010
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the efficacy and safety of a six month double-mask treatment of tasimelteon or placebo in male and female subjects with Non-24-Hour Sleep-Wake Disorder
Conditions
- Non-24-Hour Sleep-Wake Disorder
Interventions
tasimelteonDrug
20 mg tasimelteon capsules, PO daily for 6 months
PlaceboDrug
Placebo capsules, PO daily for 6 months
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of Patients Entrained as Assessed by Urinary aMT6Time frame: 1 month
- Proportion of Patients With a Clinical Response: Entrainment of aMT6 and Score of ≥ 3 on N24CRSTime frame: 6 months
Locations
28 sites in 2 countries. Site status is shown where the registry gives one.
Pulmonary Associates, PA
Phoenix, Arizona
SDS Clinical Trials Inc.
Orange, California
VA Palo Alto Health Care System/PAIRE (San Fransisco Bay Area)
Palo Alto, California
St. Johns Sleep Disorder Center - St. Johns Medical Plaza
Santa Monica, California
Radiant Research - Denver
Denver, Colorado
PAB Clinical Research Inc.
Brandon, Florida
Kendall South Medical Center, Inc.
Miami, Florida
Ocean Sleep Disorders Center - Ormond Beach
Ormond Beach, Florida
Sleep Disorders Center Of Georgia
Atlanta, Georgia
Suburban Lung Associates SC (Chicago Metropolitan Area)
Elk Grove Village, Illinois
The Center for Sleep and Wake Disorders (Washington, D.C. Metropolitan Area)
Chevy Chase, Maryland
Brigham and Women's Hospital
Boston, Massachusetts
Michigan Head-Pain Neurological Institute
Ann Arbor, Michigan
St. Luke's Sleep Medicine and Research Center (St. Louis Metropolitan Area)
Chesterfield, Missouri
New York Eye and Ear Infirmary
New York, New York
Tri-State Sleep Disorders Center
Cincinnati, Ohio
Ohio Sleep Medicine Institute (Columbus Metropolitan Area)
Dublin, Ohio
Lynn Health Science Institute
Oklahoma City, Oklahoma
Columbia Research Group Inc.
Portland, Oregon
Center For Sleep Medicine at Chestnut Hill Hospital
Philadelphia, Pennsylvania
Consolidated Clinical trials
Pittsburgh, Pennsylvania
SleepMed, Inc. - Columbia
Columbia, South Carolina
Todd J. Swick, M.D., P.A.
Houston, Texas
Advanced Sleep Research GmbH
Berlin, Germany
Bergmannsheil University Hospital - Medical Clinic III
Bochum, Germany
Klinische-Forschung Hannover Mitte
Hanover, Germany
Universitaetsklinikum Glesen and Marburg gmbH/Schlaflabor - Sleep Lab University Marburg
Marburg, Germany
Bonomed Studiezentrum
Munich, Germany
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.